A Study of Mirikizumab Solution (LY3074828) in Healthy Participants
Clinical trial NCT07446101 · RECRUITING
Trial details
- NCT number
- NCT07446101
- Sponsor
- Eli Lilly and Company
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-24
- Primary completion
- 2027-02-01
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.